Concerns over disagreements between the interpretation of medical images performed by investigators and those performed by blinded independent reviewers (BICR) accompany most trials that involve imaging biomarkers. This article by Dr. Surabhi Bajpai and Dr. Manish Sharma at Calyx is intended to be a brief introduction to this topic and provides some guidance on how to manage such disagreements.